Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Utvärdering av YouControl-AFib, en mHealth-applikation för personer med förmaksflimmer

1 september 2026 uppdaterad av: University of Wisconsin, Madison

Implementering av YouControl-AFib mHealth Application (pilotversion) för att förbättra fysisk aktivitet hos personer med förmaksflimmer

This study is being done to establish the feasibility of performing a clinical trial using a mHealth application named YouControl-AFib designed to improve the cardiovascular health of persons with atrial fibrillation. The study will obtain feedback on the app design to inform future versions and will collect preliminary data to support proof-of-concept and potential effect sizes for future trial design.

Studieöversikt

Status

Avslutad

Betingelser

Detaljerad beskrivning

Primary Objective

  • To effectively recruit participants for a clinical trial and obtain user feedback on the mHealth app using the Mobile App Rating Scale and focus group sessions.

Secondary Objectives

  • To evaluate the impact of the YouControl-AFib mHealth app (pilot version, 3 months of use) on physical activity in persons with atrial fibrillation.
  • To obtain several additional functional and disease specific endpoints that will help establish possible effect sizes to be evaluated more formally in subsequent versions of the mHealth application.
  • To obtain user feedback on the mHealth app using the Mobile App Rating Scale and focus group sessions.

Studietyp

Interventionell

Inskrivning (Faktisk)

51

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Wisconsin
      • Madison, Wisconsin, Förenta staterna, 53792
        • UW School of Medicine and Public Health

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 80 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Ability to understand and the willingness to sign a written informed consent document
  • Willing to comply with all study procedures and be available for the duration of the study
  • SmartPhone capable of pairing with a Fitbit Sense 2 and Fitbit App (Apple iOS 15 and higher or Android 10 or higher)
  • Paroxysmal or persistent atrial fibrillation verified by 12-lead electrocardiogram (ECG) or other clinical grade monitoring
  • body mass index (BMI) greater than 27

Exclusion Criteria:

  • History of permanent atrial fibrillation
  • Left ventricular ejection fraction (LVEF) less than 45 percent
  • Myocardial infarction, coronary artery bypass grafting, or valve surgery within the last 12 months
  • Moderate to severe valve disease
  • Inability to participate in a structured exercise program due to musculoskeletal disease
  • Already participating in a structured exercise program or achieving guideline directed physical activity
  • Planned surgery or procedure during the next three months that limit ability to engage in physical activity

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Personer som använder YouControl-A-Fib-appen

Participants will use the app for 3 months, includes 1 month phone call with Health Coach

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Average Number of Participants Recruited Per Month
Tidsram: up to 6 months
up to 6 months
Maximum Number of Participants Recruited in a Single Month
Tidsram: up to 6 months
up to 6 months
Mobile App Rating Scale Score
Tidsram: 3 months

Mobile App Rating Scale contains several subscales that will each be scored on a scale of 1-5; B-functionality, C-aesthetics, and D-information. Higher scores indicate high levels of functionality, aesthetics, and information quality. The overall mean score for all sub-scales is reported here.

3 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in 6-minute Walk Distance (Compared to Baseline for Each Participant) After Using the mHealth App for 3 Months
Tidsram: baseline, 3 months
baseline, 3 months
Weekly Step Count After Using the mHealth App for Three Months
Tidsram: week 1, week 12
week 1, week 12
Intentional Activity Time (in One Week) After Using the mHealth App for Three Months
Tidsram: week 1, week 12
week 1, week 12
General Quality of Life Questionnaire: SF-12 Physical Component Summary Score
Tidsram: baseline, 3 months

SF-12 measures the impact of health on the participant's life and is scored from 0-100 where higher scores indicates higher health related quality of life.

baseline, 3 months
General Quality of Life Questionnaire: SF-12 Mental Component Summary Score
Tidsram: baseline, 3 months

SF-12 measures the impact of health on the participant's life and is scored from 0-100 where higher scores indicates higher health related quality of life.

baseline, 3 months
Patient Health Questionnaire (PHQ-9) Score
Tidsram: baseline, 3 months

PHQ-9 is a 9-item questionnaire scored on a 4 point likert scale from 0-3 for a total possible range of scores from 0-27. Higher scores indicate increased depression.

baseline, 3 months
Change in Atrial Fibrillation Effect on Quality of Life Questionnaire (AFEQT) Score
Tidsram: baseline, 3 months

AFEQT is a 20-item survey scored on a 7 point likert scale from 1-7 (total possible range of scores is converted to be from 0-100) where higher scores indicate higher effect that atrial fibrillation has on the participant's quality of life.

baseline, 3 months
Atrial Fibrillation Symptom Severity (AFSS) Score
Tidsram: baseline, 3 months

AFSS is a 7-item survey scored on a likert scale from 0-5 for a total possible range of scores from 0-35 where higher scores indicate greater symptom severity.

baseline, 3 months
Percent Correct on the Atrial Fibrillation Knowledge Assessment Tool (AFKAT)
Tidsram: baseline, 3 months

AFKAT is a 21-item true / false assessment that measures knowledge about atrial fibrillation. Correct answers are scored with a 1 for a total possible range of scores from 0-21. Higher scores indicate increased knowledge of atrial fibrillation. Reported here is the percent correct.

baseline, 3 months
Life's Essential 8 Score After Using the mHealth App for Three Months
Tidsram: baseline, 3 months

Life's Essential 8 score (LE8) is a composite score between 0-100 that assesses a participant's adherence to 8 lifestyle recommendations with improve cardiovascular health: diet, physical activity, smoking habits, body mass index, cholesterol, blood glucose, and sleep duration. Higher scores are indicative of higher adherence to healthy lifestyle.

baseline, 3 months
Irregular Heart Rate Notifications (in One Week) After Using the mHealth App for Three Months
Tidsram: baseline, 3 months
baseline, 3 months

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in ECG-age After Using the mHealth App for Three Months
Tidsram: baseline, 3 months

Participants will obtain single-lead ECGs at baseline and after three months. The time-voltage data are run through an ECG-AI model for estimating ECG-age. ECG-age is a novel metric developed by investigators at Wake Forest. See reference section for relevant publication describing a similar model. Summary results will be reported as ECG-age in years.

baseline, 3 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Matthew M Kalscheur, MD, UW School of Medicine and Public Health

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

17 oktober 2024

Primärt slutförande (Faktisk)

22 juli 2025

Avslutad studie (Faktisk)

22 juli 2025

Studieregistreringsdatum

Först inskickad

22 augusti 2024

Först inskickad som uppfyllde QC-kriterierna

27 augusti 2024

Första postat (Faktisk)

28 augusti 2024

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

25 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

1 september 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 2024-0954
  • A534225 (Annan identifierare: UW Madison)
  • Protocol Version 8/6/2024 (Annan identifierare: UW Madison)
  • 1UL1TR002373 (U.S.S. NIH-anslag/kontrakt)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-planbeskrivning

This study will comply with the NIH Data Sharing Policy and Policy on the Dissemination of NIH-Funded Clinical Trial Information and the Clinical Trials Registration and Results Information Submission rule. As such, this trial will be registered at ClinicalTrials.gov, and results information from this trial will be submitted to ClinicalTrials.gov. Every attempt will be made to publish results in peer-reviewed journals.

Tidsram för IPD-delning

Data from this study may be requested from other researchers 7 years after the completion of the primary endpoint by contacting the PI.

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL
  • SAV
  • ICF

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Ja

produkt tillverkad i och exporterad från U.S.A.

Ja

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera